Transaction · 0001817199-26-000030

Ring Christine

Ring Christine, CLO, reported an open-market or private sale at Nurix Therapeutics, Inc. involving 5387.000000 shares for an estimated $138417.35. Reported holdings after the transaction were 9510.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCLO
NRIXNurix Therapeutics, Inc.
Filing timeSep 02
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$25.82
Pre-filing
1mo ago -10.1%1w ago +5.4%1d ago +5.4%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

NRIX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NRIX since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001817199-26-000030
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 02, 2026, 11:42 PM · 0d delay
Shares
5.38k sh
$2.56k per share
Estimated value
-$13.8M
Computed from shares × price
Holdings after
9.51k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

  2. F2

    Represents the weighted average sale price. The lowest price at which shares were sold was $25.41 and the highest price at which shares were sold was $26.23. The Reporting Person undertakes to provide…

  3. F3

    Represents the weighted average sale price. The lowest price at which shares were sold was $26.46 and the highest price at which shares were sold was $26.73. The Reporting Person undertakes to provide…

  4. F4

    The stock option vests as to 1/36 of the total shares monthly beginning March 13, 2024, until the option is fully vested on February 13, 2027, subject to the Reporting Person's provision of service to…

Original filing · 0001817199-26-000030
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NRIX